Zobrazeno 1 - 10 of 91 pro vyhledávání: '"Sinnige H"'
1
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
Autor: Janssen, J J W M, Löwenberg, B, Manz, M, Biemond, B J, Westerweel, P E, Klein, S K, Fehr, M, Sinnige, H A M, Efthymiou, A, Legdeur, M C J C, Pabst, T, Gregor, M, van der Poel, M W M, Deeren, D, Tick, L W, Jongen-Lavrencic, M, van Obbergh, F, Boersma, R S, de Weerdt, O, Chalandon, Y, Heim, D, Spertini, O, van Sluis, G, Graux, C, Stüssi, G, van Norden, Y, Ossenkoppele, G J
Publikováno v: Janssen, J J W M, Löwenberg, B, Manz, M, Biemond, B J, Westerweel, P E, Klein, S K, Fehr, M, Sinnige, H A M, Efthymiou, A, Legdeur, M C J C, Pabst, T, Gregor, M, van der Poel, M W M, Deeren, D, Tick, L W, Jongen-Lavrencic, M, van Obbergh, F, Boersma, R S, de Weerdt, O, Chalandon, Y, Heim, D, Spertini, O, van Sluis, G, Graux, C, Stüssi, G, van Norden, Y & Ossenkoppele, G J 2022, ' Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome ', Leukemia, vol. 36, no. 9, pp. 2189-2195 . https://doi.org/10.1038/s41375-022-01657-3
Leukemia, 36(9), 2189-2195. Nature Publishing Group
Leukemia, Vol. 36, no.9, p. 2189-2195 (2022)
Leukemia, 36, 2189-2195. Nature Publishing Group
Treatment results of AML in elderly patients are unsatisfactory. In an open label randomized phase II study, we investigated whether addition of the XPO1 inhibitor selinexor to intensive chemotherapy would improve outcome in this population. 102 AML
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::287a701a807a9162ad042541d5d386bd
http://www.scopus.com/inward/record.url?scp=85134692962&partnerID=8YFLogxK
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Perioperative bridging of anticoagulation: Towards a more reserved approach
Autor: Mol, G. C. M., Büller, H. R., Sinnige, H. A. M., Péquériaux, N. C. V., Coppens, M.
Publikováno v: Netherlands journal of medicine, 77(8), 280-286. Van Zuiden Communications BV
Background: Most invasive procedures require the interruption of oral anticoagulation. In 2015, an international randomised trial demonstrated that perioperative bridging caused more harm than benefit in most anticoagulated patients with atrial fibri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::bf49acc308f9aaf3c78a301ff8e4ea14
https://pure.amc.nl/en/publications/perioperative-bridging-of-anticoagulation-towards-a-more-reserved-approach(10d3cd68-eede-4e54-8032-81373c555e4d).html
Zobrazit plný text záznamu
4
Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group
Autor: Stege, C A M, Van Der Holt, B, Mellqvist, U H, Levin, M D, Salomo, M, Abildgaard, N, Bos, G, Visser-Wisselaar, H, Hansson, M, Van Der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S, Tanis, B, Szatkowski, D L, Brouwer, R, Westerman, M, Leijs, M B, Sinnige, H, Haukaas, E, Van Der Hem, K, Durian, M, Mattijssen, V, Gimsing, P, Van De Donk, N W C J, Stevens-Kroef, M, Sonneveld, P, Waage, A, Zweegman, S
Publikováno v: Stege, C A M, van der Holt, B, Mellqvist, U-H, Levin, M-D, Salomo, M, Abildgaard, N, Bos, G, Visser-Wisselaar, H, Hansson, M, van der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S, Tanis, B, Szatkowski, D L, Brouwer, R, Westerman, M, Leijs, M B, Sinnige, H, Haukås, E, van der Hem, K, Durian, M F, Mattijssen, V, Gimsing, P, Van De Donk, N WCJ, Stevens-Kroef, M, Sonneveld, P, Waage, A & Zweegman, S 2017, ' Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group ', Blood, vol. 130, no. Suppl. 1, 3146 . < http://www.bloodjournal.org/content/130/Suppl_1/3146.full?sso-checked=true >
Stege, C A M, Van Der Holt, B, Mellqvist, U H, Levin, M D, Salomo, M, Abildgaard, N, Bos, G, Visser-Wisselaar, H, Hansson, M, Van Der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S, Tanis, B, Szatkowski, D L, Brouwer, R, Westerman, M, Leijs, M B, Sinnige, H, Haukaas, E, Van Der Hem, K, Durian, M, Mattijssen, V, Gimsing, P, Van De Donk, N W C J, Stevens-Kroef, M, Sonneveld, P, Waage, A & Zweegman, S 2017, Frailty predicts survival and toxicity in newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation; report of the HOVON-87/NMSG-18 study group . in Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH . Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH, vol. 130 . < http://www.bloodjournal.org/content/130/Suppl_1/3146 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emexa&AN=620335289 >
Stege, C A M, Sonneveld, P, Plesner, T, Stevens-Kroef, M, van der Holt, B, Zweegman, S, Waage, A, Klein, S, Sinnige, H, Mellqvist, U-H, Abildgaard, N, Durian, M F, Hansson, M, Levin, M-D, Leijs, M B, Szatkowski, D L, Haukås, E, Salomo, M, Bos, G, Visser-Wisselaar, H, van der Velden, A, Deenik, W, Gruber, A, Coenen, J L L M, Tanis, B, Brouwer, R, Westerman, M, van der Hem, K, Mattijssen, V, Gimsing, P & Van De Donk, N WCJ 2017, ' Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group ', 59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA , Atlanta, United States, 09/12/2017-12/12/2017 .
Blood. Conference: 59th Annual Meeting of the American Society of Hematology, ASH
Introduction We previously reported the results of the phase III randomized HOVON-87/NMSG-18 study for Newly Diagnosed Multiple Myeloma patients not eligible for stem cell transplantation (nte-NDMM). The efficacy of melphalan, prednisolone and either
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::de954831a83b2ea33933ff13b8607d91
http://www.bloodjournal.org/content/130/Suppl_1/3146.full?sso-checked=true
Zobrazit plný text záznamu
6
Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group
Autor: Labar, B., Suciu, S., Willemze, R., Muus, P., Marie, J.P., Fillet, G., Berneman, Z., Jaksic, B., Feremans, W., Bron, D., Sinnige, H., Mistrik, M., Vreugdenhil, G., Bock, R. de, Nemet, D., Gilotay, C., Amadori, S., Witte, T. de, EORTC Leukemia Grp
Publikováno v: Haematologica, 95, 1489-95
Haematologica, 95(9), 1489-1495
Haematologica
Haematologica, 95, 9, pp. 1489-95
Contains fulltext : 88800.pdf (Publisher’s version ) (Open Access) BACKGROUND: Corticosteroids are a standard component of the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma. Our aim was to determine whether dexamethasone resu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3934e4312a48163e76521acb7948a7ab
https://hdl.handle.net/1887/110181
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje